Abbott Launches New App To Keep Heart Failure Patients Out Of The Hospital
Abbott Launches New App To Keep Heart Failure Patients Out Of The Hospital
$131.00
Abbott’s Merlin patient care network works with the CardioMEMS HF sensor system. The Merlin 10.0 update to the network allows physicians to share custom messages directly with their patients. Medtech Insight looks closer at the software and its intended benefits.
Author: Informa Pharma Intelligence
Publisher: Medtech
- Description
Abbott is rolling out Merlin 10.0, a new version for the company’s remote follow-up system for importing and managing information for heart failure patients using the CardioMEMS HF sensor system that will enable physicians to send patients and their caregivers custom messages through the mobile app. The company shares how this aims to improve patient compliance through ongoing, interactive dialogue between heart failure patients and the professionals caring for them. Medtech Insight covers the history of this software, its benefits to date, and role connected devices play in managing heart failure.
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the